Search Results - "Barro, Christian"

Refine Results
  1. 1

    Serum neurofilament light levels in normal aging and their association with morphologic brain changes by Khalil, Michael, Pirpamer, Lukas, Hofer, Edith, Voortman, Margarete M., Barro, Christian, Leppert, David, Benkert, Pascal, Ropele, Stefan, Enzinger, Christian, Fazekas, Franz, Schmidt, Reinhold, Kuhle, Jens

    Published in Nature communications (10-02-2020)
    “…Neurofilament light (NfL) protein is a marker of neuro-axonal damage and can be measured not only in cerebrospinal fluid but also in serum, which allows for…”
    Get full text
    Journal Article
  2. 2

    Blood neurofilament light chain as a biomarker of MS disease activity and treatment response by Kuhle, Jens, Kropshofer, Harald, Haering, Dieter A, Kundu, Uma, Meinert, Rolf, Barro, Christian, Dahlke, Frank, Tomic, Davorka, Leppert, David, Kappos, Ludwig

    Published in Neurology (05-03-2019)
    “…OBJECTIVETo assess the value of blood neurofilament light chain (NfL) as a biomarker of recent, ongoing, and future disease activity and tissue damage and its…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD by Watanabe, Mitsuru, Nakamura, Yuri, Michalak, Zuzanna, Isobe, Noriko, Barro, Christian, Leppert, David, Matsushita, Takuya, Hayashi, Fumie, Yamasaki, Ryo, Kuhle, Jens, Kira, Jun-ichi

    Published in Neurology (24-09-2019)
    “…OBJECTIVETo test the hypothesis that serum levels of glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL), which are an intermediate…”
    Get full text
    Journal Article
  7. 7

    Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis by Siller, Nelly, Kuhle, Jens, Muthuraman, Muthuraman, Barro, Christian, Uphaus, Timo, Groppa, Sergiu, Kappos, Ludwig, Zipp, Frauke, Bittner, Stefan

    Published in Multiple sclerosis (01-04-2019)
    “…Background: Monitoring neuronal injury remains one key challenge in early relapsing-remitting multiple sclerosis (RRMS) patients. Upon axonal damage,…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Fluid biomarker and electrophysiological outcome measures for progressive MS trials by Barro, Christian, Leocani, Letizia, Leppert, David, Comi, Giancarlo, Kappos, Ludwig, Kuhle, Jens

    Published in Multiple sclerosis (01-10-2017)
    “…Progressive multiple sclerosis (MS) is characterized by insidious clinical worsening that is difficult to accurately quantify and predict. Biofluid markers and…”
    Get full text
    Journal Article
  10. 10

    Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy by Lieverloo, Gwen G. A., Wieske, Luuk, Verhamme, Camiel, Vrancken, Alexander F. J., Doorn, Pieter A., Michalak, Zuzanna, Barro, Christian, Schaik, Ivo N., Kuhle, Jens, Eftimov, Filip

    Published in Journal of the peripheral nervous system (01-06-2019)
    “…Axonal damage in chronic inflammatory demyelinating polyneuropathy (CIDP) is the main predictor of poor outcome. We hypothesized that serum neurofilament light…”
    Get full text
    Journal Article
  11. 11

    Fingolimod in children with Rett syndrome: the FINGORETT study by Naegelin, Yvonne, Kuhle, Jens, Schädelin, Sabine, Datta, Alexandre N, Magon, Stefano, Amann, Michael, Barro, Christian, Ramelli, Gian Paolo, Heesom, Kate, Barde, Yves-Alain, Weber, Peter, Kappos, Ludwig

    Published in Orphanet journal of rare diseases (06-01-2021)
    “…Rett syndrome (RS) is a severe neurodevelopmental disorder for which there is no approved therapy. This study aimed to assess safety and efficacy of oral…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Validation of Two Kinetic Assays for the Quantification of Endotoxin in Human Serum by Barro, Christian, Paul, Anu, Saleh, Fermisk, Chitnis, Tanuja, Weiner, Howard L.

    Published in Frontiers in neurology (25-06-2021)
    “…Background: There is an emerging evidence of the role of the microbiome in neurological diseases. Endotoxin is a component of gram-negative bacteria and…”
    Get full text
    Journal Article
  15. 15

    Blood neurofilament light as a potential endpoint in Phase 2 studies in MS by Sormani, Maria Pia, Haering, Dieter A., Kropshofer, Harald, Leppert, David, Kundu, Uma, Barro, Christian, Kappos, Ludwig, Tomic, Davorka, Kuhle, Jens

    “…Objectives To assess whether neurofilament light chain (NfL) could serve as an informative endpoint in Phase 2 studies in patients with relapsing–remitting…”
    Get full text
    Journal Article
  16. 16

    Serum Neurofilament Light Chain Is Associated with Incident Lacunes in Progressive Cerebral Small Vessel Disease by Peters, Nils, van Leijsen, Esther, Tuladhar, Anil M., Barro, Christian, Konieczny, Marek J., Ewers, Michael, Lyrer, Philippe, Engelter, Stefan T., Kuhle, Jens, Duering, Marco, de Leeuw, Frank-Erik

    Published in Journal of stroke (01-09-2020)
    “…Background and Purpose Serum neurofilament light (NfL)-chain is a circulating marker for neuroaxonal injury and is also associated with severity of cerebral…”
    Get full text
    Journal Article
  17. 17

    Impact of parturition on maternal cardiovascular and neuronal integrity in a high risk cohort - a prospective cohort study by Evers, Katrina Suzanne, Huhn, Evelyn Annegret, Fouzas, Sotirios, Barro, Christian, Kuhle, Jens, Fisch, Urs, Bernasconi, Luca, Lapaire, Olav, Wellmann, Sven

    Published in BMC pregnancy and childbirth (05-11-2019)
    “…To better understand the profound multisystem changes in maternal physiology triggered by parturition, in particular in the underexplored neuronal system, by…”
    Get full text
    Journal Article
  18. 18

    Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury by Depoorter, Antoinette, Neumann, Roland P, Barro, Christian, Fisch, Urs, Weber, Peter, Kuhle, Jens, Wellmann, Sven

    Published in Frontiers in neurology (20-11-2018)
    “…Neurofilament light chain (NfL) is a highly promising biomarker of neuroaxonal injury that has mainly been studied in adult neurodegenerative disease. Its…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high‐dose pharmaceutical‐grade biotin (MD1003) by Collongues, Nicolas, Kuhle, Jens, Tsagkas, Charidimos, Lamy, Julien, Meyer, Nicolas, Barro, Christian, Parmar, Katrin, Amann, Michael, Wuerfel, Jens, Kappos, Ludwig, Moreau, Thibault, Seze, Jerome

    Published in Brain and behavior (01-02-2021)
    “…Background High‐dose pharmaceutical‐grade biotin (MD1003) has positive effects on disability in progressive multiple sclerosis (PMS), but its mechanism of…”
    Get full text
    Journal Article